The pathophysiology of lupus erythematosus

European Journal of Dermatology

Volumn 8, Issue 1, 1998, Pages 4-7

  Vanholder, Raymond ^a   De Keyser, Filip ^a   Kips, Johan ^a   Praet, Marleen ^a   Naeyaert, Jean Marie ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Lupus erythematosus; Lupus like syndromes

Indexed keywords

AUTOANTIBODY; CHLORPROMAZINE; DNA; HISTONE; HLA DR2 ANTIGEN; HLA DR3 ANTIGEN; HYDRALAZINE; ISONIAZID; METHYLDOPA; PENICILLAMINE; PROCAINAMIDE; QUINIDINE; SALAZOSULFAPYRIDINE; SEX HORMONE;

AUTOIMMUNE DISEASE; BLOOD CLOTTING DISORDER; COMPLEMENT DEFICIENCY; DISEASE PREDISPOSITION; DNA HISTONE INTERACTION; DNA MODIFICATION; DNA STRUCTURE; ENVIRONMENTAL FACTOR; HEREDITY; IMMUNOSTIMULATION; LUPUS ERYTHEMATOSUS; PHOTOSENSITIVITY; PREGNANCY; RACE DIFFERENCE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; ULTRAVIOLET RADIATION;

CAUSALITY; FEMALE; HUMANS; INCIDENCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PREGNANCY; PROGNOSIS; RISK FACTORS;

EID: 0031777319     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Goldman M. Cytokines in the pathophysiology of systemic lupus erythematosus. Autoimmunity 1990; 8: 173-9.
2. Spronk PE, Borg EJ, Huitema MG, Limburg PC, Kellenberg CGM. Changes in levels of soluble T-cell activation markers, slL-2R, sCD4 and sCD8, in relation to disease exacerbations in patients with systemic lupus erythematosus: a prospective study. Ann Rheum Dis 1994; 53: 235-9.
3. Meryhew NL, Shaver C, Messner RP, Runquist OA. Mononuclear phagocyte system dysfunction in murine SLE: abnormal clearance kinetics precede clinical disease. J Lab Clin Med 1991; 117: 181-93.
4. Pallis M, Robson DK, Haskard DO, Powell RJ. Distribution of cell adhesion molecules in skeletal muscle from patients with systemic lupus erythematosus. Ann Rheum Dis 1993; 52: 667-71.
5. Escolar G, Font J, Reverter JC, Lopez-Soto A, Garrido M, Cervera R, Ingelmo M, Castillo R, Ordinas A. Plasma from systemic lupus erythematosus patients with antiphospholipid antibodies promotes platelet aggregation. Arterioscler Thromb 1992; 12: 196-200.
6. Hopkinson ND, Doherty M, Powell RJ. Clinical features and race-specific incidence/prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients. Ann Rheum Dis 1994; 53: 675-80.
7. Reveille JD, Bartolucci A, Alarcon GS. Prognosis in systemic lupus erythematosus. Arthr Rheum 1990; 33: 37-48.
8. Petri M, Perez-Gutthann S, Longenecker JC, Hochberg M. Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am J Med 1991; 91: 345-53.
9. MacAlindon T, Giannotta L, Taub N, D'Cruz D, Hughes G. Environmental factors predicting nephritis in systemic lupus erythematosus. Ann Rheum Dis 1993; 52: 720-4.
10. Freedman BI, Spray BJ, Heise ER, Espeland MA, Canzanello VJ. A race-controlled human leukocyte frequency analysis in lupus nephritis. Am J Kidney Dis 1993; 21: 378-82.
11. Arnett FC. Genetic aspects of human lupus. Clin Immunol 1992; 63: 4-6.
12. Lewkonia RM. The clinical genetics of lupus. Lupus 1992; 1: 55-62.
13. Arnett FC, Reveille JD. Genetics of systemic lupus erythematosus. Rheum Dis Clin North Am 1992; 18: 865-92.
14. Wilson AG, Gordon C, di Giovine FS, de Vries N, van de Putte LBA, Emery P, Duff GW. A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur J Immunol 1994; 24: 191-5.
15. Nilsson UR, Nilsson B, Storm KE, Sjölin-Forsberg G, Hällgren R. Hereditary dysfunction of the third component of complement associated with a systemic lupus erythematosus-like syndrome and meningococcal meningitis. Arthr Rheum 1992; 35: 580-6.
16. Sequeira JF, Keser G, Greenstein B, Wheeler MJ, Duarte PC, Khamashta MA, Hughes GRV. Systemic lupus erythematosus: sex hormones in male patients. Lupus 1993; 2: 315-7.
17. Le Thi Huong D, Wechsler B, Piette JC, Bletry O, Godeau P. Pregancy and its outcome in systemic lupus erythematosus. Q J Med 1994; 87: 721-9.
18. Petri M. Systemic lupus erythematosus end pregnancy. Rheum Dis Clin North Am 1994; 20: 87-118.
19. Lockshin MD. Pregnancy does not cause systemic lupus erythematosus to worsen. Arthr Rheum 1989; 32: 665-70.
20. Derksen RHWM, Bruinse HW, de Groot PG, Kater L. Pregnancy in systemic lupus erythematosus: a prospective study. Lupus 1994; 3: 149-55.
21. Urowitz MB, Gladman DD, Farewell VT, Stewart J, MacDonald J. Lupus and pregnancy studies. Arthr Rheum 1993; 10: 1392-7.
22. Packham DK, Lam SS, Nicholls K, Fairley KF, Kincaid-Smith PS. Lupus nephritis and pregnancy. Q J Med 1992; 83: 315-24.
23. Golan TD, Elkon KB, Gharavi AE, Krueger JG. Enhanced membrane binding of autoantibodies to cultured keratinocytes of systemic lupus erythematosus patients after ultraviolet B/ultraviolet A irradiation. J Clin Invest 1992; 90: 1067-76.
24. Golan TD, Foltyn V, Roueff A. Increased susceptibility to in vitro ultraviolet B radiation in fibroblasts and lymphocytes cultured from systemic lupus erythematosus patients. Clin Immunol Immunopathol 1991; 58: 289-304.
25. Jones DRE, Hopkinson ND, Powell RJ. Autoantibodies in pet dogs owned by patients with systemic lupus erythematosus. Lancet 1992; 339: 1378-80.
26. Love LA. New environmental agents associated with lupus-like disorders. Lupus 1994; 3: 467-71.
27. Hess EV. Environmental lupus syndromes. Brit J Rheumatol 1995; 34: 597-601.
28. Alarcon-Segovia D, Kraus A. Drug-related lupus syndromes and their relationship to spontaneously occurring systemic lupus erythematosus. Ball Clin Rheumatol 1991; 5: 1-12.
29. Yung RL, Richardson BC. Drug-induced lupus. Rheum Dis Clin North Am 1994; 20: 61-86.
30. Fritzler MJ. Drugs recently associated with lupus syndromes. Lupus 1994; 3: 455-9.
31. Reidenberg MM, Drayer DE, Lorenzo B, Strom BL, West SL, Snyder ES, Freundlich B, Stolley PD. Acetylation phenotypes and environmental chemical exposure of people with idiopathic systemic lupus erythematosus. Arthr Rheum 1993; 36: 971-3.
32. Jiang X, Khursigara G, Rubin RL. Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils. Science 1994; 266: 810-3.
33. Uetrecht JP. Idiosyncratic drug reactions: possible role of reactive metabolites generated by leukocytes. Pharmaceut Res 1989; 6: 265-73.
34. Yung RL, Quddus J, Chrisp CE, Johnson KJ, Richardson BC. Mechanisms of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo. J Immunol 1995; 154: 3025-35.
35. Zacharias W, Koopman WJ. Lupus-inducing drugs alter the structure of supercoiled circular DNA domains. Arthr Rheum 1990; 33: 366-74.
36. Rubin RL, Bell SA, Burlingame RW. Autoantibodies associated with lupus induced by diverse drugs target a similar epitope in the (H2A-H2B)-DNA complex. J Clin Invest 1992; 90: 165-73.
37. Burlingame RW, Boey ML, Starkebaum G, Rubin RL. The central role of chromatin in autoimmune response to histones and DNA in systemic lupus erythematosus. J Clin Invest 1994; 94: 184-92.